Splicing Factor Proline And Glutamine Rich

Splicing Factor Proline and Glutamine Rich (SFPQ), also known as PSF, is a protein that in humans is encoded by the SFPQ gene. This protein plays a critical role in the process of alternative splicing, a mechanism by which a single gene can give rise to multiple forms of mRNA, leading to the production of different proteins. SFPQ is particularly noted for its involvement in the regulation of gene expression, DNA repair, and its association with various diseases.

Function

SFPQ is a component of the spliceosome complex that is essential for the splicing of pre-mRNA into mature mRNA. It is characterized by its rich content of proline and glutamine amino acids. The protein functions not only in splicing but also in the regulation of gene expression by interacting with both DNA and RNA. It has been implicated in the maintenance of genomic integrity, participating in DNA repair processes. Furthermore, SFPQ is involved in the regulation of transcription, acting as a transcriptional repressor or activator depending on the context.

Structure

The SFPQ protein contains a proline/glutamine-rich domain that facilitates its interaction with nucleic acids. It also possesses an RNA recognition motif (RRM) that is crucial for its role in RNA binding and splicing regulation. The structure of SFPQ enables it to form heterodimers with other proteins, such as NONO (Non-POU domain-containing octamer-binding protein), enhancing its functionality in RNA processing and gene regulation.

Clinical Significance

Alterations in the expression or function of SFPQ have been linked to several diseases. It has been associated with neurodegenerative diseases, such as Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD), where mutations affecting the SFPQ protein can lead to the disruption of normal RNA processing. Additionally, SFPQ has been implicated in cancer biology, with changes in its expression levels observed in various types of cancer, including breast and prostate cancer. Its role in DNA repair mechanisms also highlights its potential as a target for therapeutic interventions in cancer treatment.

Research Directions

Current research on SFPQ is focused on understanding its precise mechanisms of action in RNA processing and gene regulation, as well as elucidating its involvement in disease pathogenesis. Studies are also exploring the potential of targeting SFPQ for therapeutic purposes, particularly in the context of neurodegenerative diseases and cancer.

See Also

• Alternative splicing
• RNA splicing
• Gene expression
• DNA repair

• Need help finding a doctor or specialist anywhere in the world? WikiMD's DocFinder can help with millions of doctors!

This article is a stub. Help WikiMD grow by registering to expand it. Editing is available only to registered and verified users. About WikiMD: A comprehensive, free health & wellness encyclopedia.